| HOME >> BIOLOGY >> TECHNOLOGY |
development 1,617,000 973,000 3,113,000 1,935,000
Total operating
expenses 3,974,000 3,273,000 7,890,000 6,547,000
Interest and other
income 347,000 454,000 754,000 920,000
Net loss ($1,717,000) ($2,030,000) ($4,017,000) ($3,126,000)
Basic and diluted
net loss per
common share ($0.03) ($0.04) ($0.07) ($0.06)
Shares used in
computing per share
data 55,701,175 55,140,675 55,680,342 55,022,221
THERMOGENESIS CORP.
Condensed Statements of Cash Flows
(Unaudited)
Six Months Ended
December 31,
2007 2006
Cash flows from operating activities:
Net loss ($4,017,000) ($3,126,000)
Adjustments to reconcile net loss to net
cash used in operating activities:
Depreciation and amortization 265,000 228,000
Stock based compensation expense 1,121,000 582,000
Accretion of discount on short-term
investments (564,000) (690,000)
Net change in operating assets and liabilities:
Accounts receivable, net 123,000 376,000
Inventories, net (191,000) (1,542,000)
Other current assets 204,000 138,000
Other assets 45,000 (15,000)
Accounts payable (434,000) 618,000
Accrued payroll and related expenses (
'/>"/>
| SOURCE ThermoGenesis Corp. Copyright©2008 PR Newswire. All rights reserved |